학술논문
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator
Document Type
Article
Author
Source
In: Scientific Reports . (Scientific Reports, December 2021, 11(1))
Subject
Language
English
ISSN
20452322